Having the opportunity to contribute to this comprehensive and important report, alongside such a wonderful team of experts, has been an absolute honour. The third report in our "New Medicines, Novel Insights" thought leadership series offers strategies for sponsors on fully integrating patients into the drug development process, optimizing trial protocols using patient insights, planning early for diversity and overcoming barriers to participation. Hear from our Chief Patient Officer Clare Grace on what a patient-guided approach looks like, and dive into the report to explore our strategies: https://lnkd.in/eXWaeccq #PatientsFirst
Jakki James’ Post
More Relevant Posts
-
Headed to the SCRS Global Site Solutions Summit? Come hear Karen McIntyre, VP of Global Site Alliances, as she joins Ken Getz and other industry leaders for a panel presentation on "Partner for Progress: Innovate for Impact," This panel discussion offers a collaborative space to explore how partnerships and innovation are driving the future of clinical trials. Whether you're looking to innovate or deepen your partnerships, this session will inspire actionable strategies to progress together toward a transformative future in clinical trials. Sunday, Sept. 29th from 10:45 – 11:30 a.m. Learn more: https://lnkd.in/eNeUQEPv
-
Loved collaborating on this New Medicines, Novel Insights newsletter with Kristina Reeder, looking at how thoughtful best practices really do make the difference in bridging the gap to bolster access for patients. #patientsfirst #novelinsights #withheart #precisiononcology
In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Jakki James and Kristina Reeder review the frustratingly limited patient access in precision oncology, the root causes, and five best practices that can bridge the gap. Learn how oncology experts are empowering patients, sites, and physicians to participate in and accelerate precision oncology. Read the full article below and subscribe to stay up to date on the latest #NovelInsights from our clinical trial newsletter! #PatientsFirst #WithHeart #PrecisionOncology #Oncology
Accelerate precision oncology by empowering and educating patients, sites, and physicians
share.parexel.social
-
Yet again, Xoli Belgrave shared her wisdom, truth and passion with the audience at #PatientsEU2024 today! #withheart #patientsfirst
“What on earth is she doing in that picture?!” I hear you ask… You can be forgiven for thinking I’m doing a strange dance solo😂 What I am actually doing is far more fun than a solo dance. It was my privilege to present at Patients as Partners EU today. The focus was on strategies for closing gaps in clinical trial participation and addressing patient data gaps. In short it’s about minding our gaps in clinical research and healthcare in general. In the picture, I am negotiating a gap to board a train. It is inspired by my childhood in London where the underground train system had massive gaps between the train and the platform. The metaphorical train is innovative clinical treatment and the platform is where patients and their loved ones are. The gap is any factor that gets in the way of accessing clinical treatment. I managed to jump into my train. What happens to those who cannot? The beauty of Patients as Partners is that it creates a space where patients, industry, and all interested partners can LEARN and ACT together. Our collective aim is to ensure nobody is left on the platform (unless they choose to stay there). Mind the gap! #PatientsEU2024 #parexel #patientsfirst #withheart❤️
-
-
Some excellent sessions at MAPS EMEA 2024 today - a great community with a shared ambition to move “from action to impact.” #MAPSEMEA24 #MedicalAffairs #JointheMovement
-
-
And so it starts - opening remarks at the biggest ever MAPS EMEA! #MAPSEMEA24 #MedicalAffairs #JointheMovement #withheart #patientsfirst Patients, health equity and holistic approaches of disease and mental wellness and the humans behind it are already key topics - great start!
-
-
Looking forward to some great sessions here in Madrid today! #MAPSEMEA24
Social Media Toolkit
s7.goeshow.com
-
Thank you Lydia Morris, PhD for being a great co-collaborator on this deeper dive into the challenges and incredible innovations within the Alzheimer’s disease landscape. I’m proud to be a small part of this incredibly important work.
The pace of trial recruitment for Alzheimer's disease is lagging behind scientific advancements, especially in early-phase clinical trials. In this blog, Parexel experts Lydia Morris, PhD and Jakki James emphasize the importance of listening to and engaging with the concerns of prospective trial participants. They also propose innovative solutions to promote earlier diagnosis in diverse populations and identify suitable surrogates for Alzheimer's patients in high-burden early-phase clinical trials. Read the latest blog from our neurosciences trial series here: https://lnkd.in/gK88apDS #Alzheimers #EarlyPhase #ClinicalResearch #PatientsFirst
-
What a lovely touch from the organisers of #ISMPPEurope2024 Thank YOU for having us, it’s been once again a great opportunity to reconnect and learn some fantastic insights in #medcomms #publications #withheart #medicalcommunications
-
